NSTG

NanoString Technologies, Inc.

Delisted

NSTG was delisted on the 13th of February, 2024.

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 0%
Negative

Positive
InvestorPlace
1 year ago
Why Is NanoString (NSTG) Stock Up 115% Today?
Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement with its existing lenders. Driving the need for such an arrangement was a bankruptcy filing at the beginning of the week.
Neutral
Business Wire
1 year ago
NanoString Announces Completion of Financing to Support Restructuring Process
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing lenders comprised of (a) $12,500,000 in new money term loans which have already been approved for funding pursuant to the February 5 interim order of the U.S. Bankruptcy court approving the credit facility, and (b) an additional $35,000,000 in new money term loa.
NanoString Announces Completion of Financing to Support Restructuring Process
Positive
InvestorPlace
1 year ago
Why Is NanoString (NSTG) Stock Up 180% Today?
Investors looking at today's price action in NanoString (NASDAQ: NSTG ) stock ought to be shaking their heads in amazement. Indeed, after announcing the company would be filing for bankruptcy protection on Monday, many thought the story with NanoString was over.
Negative
GeekWire
1 year ago
NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process
Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring a potential sale in the latest fallout from its loss in a patent infringement case against 10X Genomics.
Negative
InvestorPlace
1 year ago
Why Is NanoString Technologies (NSTG) Stock Down 59% Today?
NanoString Technologies (NASDAQ: NSTG ) stock is taking a beating on Monday after the company announced a voluntary Chapter 11 bankruptcy filing. NanoString Technologies notes that this bankruptcy filing is the result of its lost litigation battles against 10x Genomics.
Neutral
Business Wire
1 year ago
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being taken to protect its business, customers, employees and its mission to “Map the Universe of Biology.” With support from key creditors, NanoString and certain of its subsidiaries have voluntarily initiated a chapter 11 restructuring proceeding in the United States Bankruptcy.
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
Neutral
Business Wire
1 year ago
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry's first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway. Building on this breakthrough product developed for the CosMx Spatial Molecular Imager (SMI), Nan.
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
Neutral
Business Wire
1 year ago
NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString's corporate presentation on Wednesday, January 10, 20.
NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
Negative
GeekWire
1 year ago
NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq
Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.
NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq
Neutral
Business Wire
1 year ago
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString's Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as mat.
NanoString Reports Inducement Grants Under Nasdaq Listing Rules